Kriti Nutrients Reports Q1 FY26 Results: Revenue Jumps 22%, Profit Declines 35%
The announcement of quarterly financial results, particularly with a significant decline in net profit despite revenue growth, is a material event that can influence investor sentiment and the company's stock performance.
Despite a substantial increase in revenue from operations, the company reported a significant decline of over 35% in both standalone and consolidated net profit for the quarter compared to the previous year, indicating pressure on profitability.
* Kriti Nutrients Limited announced its standalone and consolidated unaudited financial results for the quarter ended 30th June 2025. * The company reported a total revenue of ₹23,108.77 lakh (₹231.09 crore) for Q1 FY26, marking a 21.95% increase compared to ₹18,947.71 lakh (₹189.48 crore) in Q1 FY25. * However, Standalone Net Profit after Tax for the quarter stood at ₹920.84 lakh (₹9.21 crore), a decrease of 35.49% from ₹1,427.26 lakh (₹14.27 crore) in the corresponding quarter of the previous year. * Consolidated Net Profit after Tax was ₹948.97 lakh (₹9.49 crore) for Q1 FY26. For comparative purposes, the consolidated figure for Q1 FY25 was ₹1,427.26 lakh (₹14.27 crore), which was based on standalone figures as per the company's notes. * Basic Earnings Per Share (EPS) on a consolidated basis was ₹1.89 for Q1 FY26, down from ₹2.85 in Q1 FY25. * The consolidated financial statements include the results of Kriti Industries (India) Limited, an Associate Company where Kriti Nutrients Limited holds 6.24% of its share capital and exercises significant influence. * The company was allotted 15,92,480 equity shares of Kriti Industries (India) Limited on 12th June 2025, following the exercise of warrants at ₹158.50 per share. This is in addition to 15,00,000 shares allotted on 11th February 2025.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.